Abstract:Purpose: Obstructive sleep apnea syndrome (OSAS) has mostly been examined using in-laboratory polysomnography (Lab-PSG), which may overestimate severity. This study compared sleep parameters in different environments and investigated the association between the plasma levels of neurochemical biomarkers and sleep parameters. Methods: Thirty Taiwanese participants underwent Lab-PSG while wearing a single-lead electrocardiogram patch. Participants' blood samples were obtained in the morning immediately after the recording. Participants wore the patch for the subsequent three nights at home. Sleep disorder indices were calculated, including the apnea-hypopnea index (AHI), chest effort index, and cyclic variation of heart rate index (CVHRI). The 23 eligible participants' derived data were divided into the normal-to-moderate (N-M) group and the severe group according to American Association of Sleep Medicine (AASM) guidelines (Lab-PSG) and the recommendations of a previous study (Rooti Rx). Spearman's correlation was used to examine the correlations between sleep parameters and neurochemical biomarker levels. Results: The mean T-Tau protein level was positively correlated with the home-based CVHRI (r = 0.53, p < 0.05), whereas no significant correlation was noted between hospital-based CVHRI and the mean T-tau protein level (r = 0.25, p = 0.25). The home-based data revealed that the mean T-Tau protein level in the severe group was significantly higher than that in the N-M group (severe group: 24.75 ± 6.16 pg/mL, N-M group: 19.65 ± 3.90 pg/mL; p < 0.05). Furthermore, the mean in-hospital CVHRI was higher than the mean at-home values (12.16 ± 13.66 events/h). Conclusion: Severe OSAS patients classified by home-based CVHRI demonstrated the higher T-Tau protein level, and CVHRI varied in different sleep environments.

High-sensitivity cardiac troponin T in obstructive sleep apnea patients without cardiovascular diseases: Efficacy of CPAP treatment.

Changes of Plasma C-reactive Protein, Endothelin-1 and Tumor Necrosis Factor-Α in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

Markers of Myocardial Ischemia in Patients With Coronary Artery Disease and Obstructive Sleep Apnea: Effect of Continuous Positive Airway Pressure Therapy

Markers of Myocardial Ischemia in Patients with Obstructive Sleep Apnea and Coronary Artery Disease

The Change of the Levels of C-reactive Protein in Patients with Obstructive Sleep Apnea Syndrome

Influence of Continuous Positive Airway Pressure Treatment on Cardiovascular Risk Factors in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

Effects of Continuous Positive Airway Pressure on Serum Inflammatory Factors in Coronary Heart Disease Patients Complicated with Obstructive Sleep Apnea-Hypopnea Syndrome

[CD69 Expression on T Cell Surface in Patients with Obstructive Sleep Apnea Hypopnea Syndrome].

Clinical Significance of the Level of TNF-α in Exhaled Breath Condensate of Patients with OSAHS

Effects of Continuous Positive Airway Pressure on C-reactive Protein and Interleukin-6 in Obstructive Sleep Apnea-hypopnea Syndrome with Hypertension

Homocysteine Level in Patients with Obstructive Sleep Apnea/hypopnea Syndrome and the Impact of Continuous Positive Airway Pressure Treatment

Erectile Dysfunction and Sexual Hormone Levels in Men with Obstructive Sleep Apnea: Efficacy of Continuous Positive Airway Pressure

Efficacy Of Continuous Positive Airway Pressure On Testosterone In Men With Obstructive Sleep Apnea: A Meta-Analysis

Association between cyclic variation in the heart rate index and biomarkers of neurodegenerative diseases in obstructive sleep apnea syndrome: A pilot study

Changes and implication of serum heart type fatty acid binding protein, high-sensitivity C-reactive protein in patients with obstructive sleep apnea hypopnea syndrome

Effect of continuous positive airway pressure on serum cystatin C among obstructive sleep apnea syndrome patients

Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome

Serum Inflammatory Factors in Patients with Obstructive Sleep Apnea Syndrome and Coronary Heart Disease

Levels and clinical value of serum homocysteine and cystatin C in patients with obstructive sleep apnea syndrome

Alterations of IGF-1, Complement C3 and Superoxide Dismutase in Patients with Moderate-to-severe Obstructive Sleep Apnea Hypopnea Syndrome.

Study on depression and level of C-reactive protein in patients with obstructive sleep apnea-hypopnea syndrome